High materiality7/10
Halozyme price target raised to $105 from $93 at Morgan Stanley
Why it may matterVerify against the original reporting
target_up
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises HALO target to $105; posted price $98.15.
- Target raised to $105 from $93; current price $98.15.
Key facts
- 01
Target: $105
- 02
Posted price: $98.15
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Sean Laaman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.